文献速递免疫规划传染病防控与疫情报告

智利W群脑膜炎球菌侵袭性疾病及ACWY结合疫苗作为控制策略的应用

Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile.
PubMed 文献 · Vaccine · 2019-10-01

智利2012年W群脑膜炎球菌侵袭性疾病(IMD)取代B群成为优势血清群,遂对9月龄至4岁儿童实施MCV-ACWY疫苗接种。2009—2016年描述性研究显示,1—4岁儿童W群发病率从2012年1.3/10万降至2016年0.1/10万,降幅92.3%,同期病死率从23%降至0%。

要点

  • 2012年W群(主要为ST-11 cc)成为智利IMD优势血清群。
  • 1—4岁儿童接种MCV-ACWY后W群发病率降低92.3%。
  • 婴儿和80岁及以上成人发病率和死亡率最高。

核心结论

  • 自2012年以来W群成为智利优势血清群,2009—2016年IMD病例持续增加,婴儿和80岁及以上人群发病率、病死率和死亡率较高。
  • MCV-ACWY提供针对W群的直接保护,大规模接种后W群发病率下降,但疫苗接种的间接效应尚未观察到。

研究设计与样本

  • 智利2009—2016年IMD病例的描述性研究,采用每10万居民累积发病率和死亡率及病死率进行描述分析,采用线性回归进行干预后趋势分析。
  • 2012年起对9月龄至4岁儿童实施全国性MCV-ACWY疫苗接种策略。

主要发现

  • 2012年W群(主要为ST-11 cc)成为优势血清群。
  • W群发病率从2009年0.01/10万升至2015年最高0.6/10万。
  • 婴儿和80岁及以上成人受累最多,2015年发病率峰值分别为9.7/10万和1.6/10万。
  • 1—4岁儿童W群发病率从2012年1.3/10万降至2016年0.1/10万,接种实施后降低92.3%。
  • 同期同年龄组病死率从23%降至0%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Serogroup causing invasive meningococcal disease (IMD) can change abruptly, as it occurred in Chile when serogroup predominance switched from MenB to MenW in 2012. As a response, a national vaccination strategy was implemented since 2012 using tetravalent meningococcal-conjugate vaccines (MCV-ACWY) in children 9 months through 4 years of age. The aim of this study was to describe IMD cases by MenW in Chile 2009-2016, and to analyse its trend after the introduction of MCV-ACWY. METHODS: Descriptive study of IMD cases in Chile, period 2009-2016. Cumulative incidence and mortality rate per 100,000 inhabitants, and case fatality rate (CRF) were used for descriptive analysis. Linear regression was used for post-intervention trend analysis. RESULTS: In 2012, MenW, mainly ST-11 cc, became predominant. MenW incidence rose from 0.01/100,000 inhabitants in 2009 to a maximum of 0.6/100,000 in 2015. Infants and adults 80 years of age and older were mostly affected, with an incidence peak of 9.7/100,000 and 1.6/100,000, respectively, in 2015. In the group of children from 1 to 4 years of age MenW incidence declined from 1.3/100,000 in 2012 to 0.1/100,000 in 2016, a 92.3% reduction after vaccination implementation. In the same period and age-cohort, CFR decreased from 23% to 0%. High mortality rates concentrated in infants and adults 80 years of age and over. CONCLUSION: MenW became predominant in Chile since 2012. IMD cases increased steadily from 2009 to 2016, with higher incidence, CFR and mortality concentrating in infants and people 80 years of age and older. MCV-ACWY provided direct protection against MenW, reducing its incidence after mass meningococcal vaccine implementation. Indirect effects of vaccination are not yet observed.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Villena R, Valenzuela MT, Bastías M, et al. Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile. Vaccine. 2019. PMID: 31585728. doi:10.1016/j.vaccine.2019.09.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。